Ekaterina B. Bukreeva

Ekaterina B. Bukreeva

Auto-generated profile, based on publicly available information

Ekaterina B. Bukreeva

Siberian State Medical University

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Journal of Biomedical Optics
Verified
Journal Article
Closed access
PDF file
Yury V. KistenevYury V. Kistenev
Yury V. Kistenev
AKAlexander I. Karapuzikov
Alexander I. Karapuzikov
NKNadezhda Yurievna Kostyukova
Nadezhda Yurievna Kostyukova
MSMarina K. Starikova
Marina K. Starikova
ABAndrey A. Boyko
Andrey A. Boyko
AKAlexey A. Karapuzikov
Alexey A. Karapuzikov
A human exhaled air analysis by means of infrared (IR) laser photoacoustic spectroscopy is presented. Eleven healthy nonsmoking volunteers (control group) and seven patients with chronic obstructive pulmonary disease (COPD, target group) were involved in the study. The principal component analysis method was used to select the most informative ranges of the absorption spectra of patients’ exhaled air in terms of the separation of the studied groups. It is shown that the data of the profiles of exhaled air absorption spectrum in the informative ranges allow identifying COPD patients in comparison to the control group.

1 July 2014 in Physics of Wave Phenomena
Verified
Journal Article
Closed access
PDF file
Yury V. KistenevYury V. Kistenev
Yury V. Kistenev
EBE. B. Bukreeva
E. B. Bukreeva
ABA. A. Bulanova
A. A. Bulanova
DKD. A. Kuzmin
D. A. Kuzmin
STS. A. Tuzikov
S. A. Tuzikov
EYE. L. Yumov
E. L. Yumov
The specificity of exhaled air spectra in the range from 9.2 to 10.6 µm for patients with lung cancer and chronic obstructive pulmonary disease has been analyzed by laser spectroscopy and...


7 October 2020 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
SPSvetlana P. PETROVNA
Svetlana P. PETROVNA
OUOlga Urazova
Olga Urazova
MVM. V. Vins
M. V. Vins
VSVladimir M. Shipulin
Vladimir M. Shipulin
APA. S. Pryakhin
A. S. Pryakhin
VNV. V. Novitsky
V. V. Novitsky
Содержание гипоксия-индуцируемых факторов и медиаторов иммуносупрессии в крови при заболеваниях, ассоциированных с гипоксией

6 December 2020 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
ОВОльга Владимировна Воронкова
Ольга Владимировна Воронкова
TSTatiana Saprina
Tatiana Saprina
ЕБЕкатерина Борисовна Букреева
Екатерина Борисовна Букреева
АЗАнастасия Павловна Зима
Анастасия Павловна Зима
The review analyzes the etiological and pathogenetic factors (including immunopathogenesis factors) of chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS), cites data on clinical and pathogenetic characteristics of combined pathology, emphasizes the commonality of risk factors and individual links of pathogenesis in syntropy.The clinical and pathogenetic features of the comorbidity of COPD and MS are closely related to the severity of chronic “metabolic” inflammation induced by elements of adipose tissue. Functional and biochemical disorders recorded in metabolic syndrome (insulin resistance, hyperglycemia, dyslipidemia) are considered as factors contributing to dysfunction of the components of innate and adaptive immunity.The review formulates a number of unresolved issues of the pathogenesis of comorbid pathology, the study of which is necessary to search for the mutual aggravating effect of COPD and MS mechanisms. In view of the clinical and laboratory metabolic syndrome equivalents variety, the authors emphasize the relevance of future studies of the pathogenetic features of chronic inflammation associated with the comorbidity of the main components of metabolic syndrome and COPD, to develop effective methods of prevention and pathogenetic therapy of comorbid pathology.

17 January 2023 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
KSK. V. Samoylov
K. V. Samoylov
EBE. B. Bukreeva
E. B. Bukreeva
VBV. V. Boyarko
V. V. Boyarko
EGE. A. Gereng
E. A. Gereng
Aim. The aim of the study was to identify the features of a new coronavirus infection in patients with chronic obstructive pulmonary disease (COPD), bronchial asthma (BA), and cardiovascular disease (CVD).Materials and Methods. The retrospective study included 58 patients with novel coronavirus infection, which were divided into four groups: group 1 comprised 12 patients with COPD and CVD; group 2 comprised 15 patients with BA and CVD; and group 3 comprised 31 patients with CVD only. All patients underwent a clinical examination, complete blood count, biochemical blood examination, coagulation testing, serum ferritin test, and multi-slice computed tomography.Results. The severity of dyspnea was greater in patients with COPD/CVD compared with BA/CVD, and in patients without bronchopulmonary pathology. The frequency of desaturation was the lowest in BA/CVD group compared with COPD/CVD and COPD/BA/CVD. A lower level of saturation was observed in COPD/CVD group in comparison with BA/CVD. The extent of lung damage also prevailed in group with COPD/CVD compared with patients without bronchopulmonary pathology. Patients with CVD only demonstrated the lowest level of leukocytes in contrast with all other study groups. However, the platelet count prevailed in the CVD group compared with the COPD/CVD group. Serum ferritin in patients with COPD/CVD was higher than in the AD/CVD group.Conclusion. Patients with COPD had more severe coronavirus infection due to severity of dyspnea, low saturation indicators, high values of ferritin, and greater severity of lung damage according to computed tomography. Patients with asthma were prone to a less severe course of coronavirus infection due to less dyspnea, rare episodes of desaturation, high saturation rates, and low ferritin values.